{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/01/3304240/8790/en/TG-Therapeutics-Announces-Publication-of-Post-Hoc-Data-from-the-Phase-3-ULTIMATE-I-II-Trials-in-Treatment-Naive-Patients-with-Relapsing-Forms-of-MS-Published-in-Frontiers-in-Immuno.html", "message": "News view counter 769647 successfully enlarged"}